← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

PRGO logoPerrigo Company plc(PRGO)Earnings, Financials & Key Ratios

PRGO•NYSE
$11.64
$1.6B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryConsumer health and OTC self-care
AboutPerrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.Show more
  • Revenue$4.25B-2.8%
  • EBITDA-$1.12B-355.7%
  • Net Income-$1.43B-729.7%
  • EPS (Diluted)-10.29-723.2%
  • Gross Margin35.14%-0.4%
  • EBITDA Margin-26.39%-363.0%
  • Operating Margin-26.39%-1122.1%
  • Net Margin-33.51%-753.2%
  • ROE-39.29%-939.2%
  • ROIC-17.14%-1665.8%
  • Debt/Equity0.01-98.5%
  • Interest Coverage-6.91-1248.7%
Technical→

PRGO Key Insights

Perrigo Company plc (PRGO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓10 consecutive years of dividend growth
  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Weak momentum: RS Rating 15 (bottom 15%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PRGO Price & Volume

Perrigo Company plc (PRGO) stock price & volume — 10-year historical chart

Loading chart...

PRGO Growth Metrics

Perrigo Company plc (PRGO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-0.79%
5 Years0.79%
3 Years-1.51%
TTM-2.75%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-729.2%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-736.59%

Return on Capital

10 Years-0.75%
5 Years-1.18%
3 Years-3.69%
Last Year-13.92%

PRGO Recent Earnings

Perrigo Company plc (PRGO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 4/12 qtrs (33%)
Q1 2026Latest
Feb 26, 2026
EPS
$0.77
Est $0.80
-3.8%
Revenue
$1.1B
Est $1.1B
+0.7%
Q4 2025
Nov 5, 2025
EPS
$0.80
Est $0.75
+6.7%
Revenue
$1.0B
Est $1.1B
-4.5%
Q3 2025
Aug 6, 2025
EPS
$0.57
Est $0.59
-3.4%
Revenue
$1.1B
Est $1.1B
-4.0%
Q2 2025
May 7, 2025
EPS
$0.60
Est $0.56
+7.1%
Revenue
$1.0B
Est $1.1B
-3.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$0.77vs $0.80-3.8%
$1.1Bvs $1.1B+0.7%
Q4 2025Nov 5, 2025
$0.80vs $0.75+6.7%
$1.0Bvs $1.1B-4.5%
Q3 2025Aug 6, 2025
$0.57vs $0.59-3.4%
$1.1Bvs $1.1B-4.0%
Q2 2025May 7, 2025
$0.60vs $0.56+7.1%
$1.0Bvs $1.1B-3.0%
Based on last 12 quarters of dataView full earnings history →

PRGO Peer Comparison

Perrigo Company plc (PRGO) competitors in Consumer health and OTC self-care — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HLN logoHLNHaleon plcDirect Competitor40.84B9.1718.74-3.96%14.46%19.9%6.56%0.52
CHGG logoCHGGChegg, Inc.Direct Competitor137.62M1.24-1.29-38.97%-27.44%-86.46%0.58
PBH logoPBHPrestige Consumer Healthcare Inc.Direct Competitor2.64B55.7513.001.1%16.9%10.19%9.22%0.57
CLAR logoCLARClarus CorporationDirect Competitor107.91M2.81-2.32-5.25%-18.59%-21.24%
TEVA logoTEVATeva Pharmaceutical Industries LimitedProduct Competitor41.76B35.8629.884.31%9.02%20.69%2.75%2.20
AMRX logoAMRXAmneal Pharmaceuticals, Inc.Product Competitor4.22B13.4160.958.05%2.39%7.47%6.4%0.13
HI logoHIHillenbrand, Inc.Product Competitor2.26B31.9852.43-15.99%1.37%2.43%0.79%1.12
MCK logoMCKMcKesson CorporationSupply Chain98.11B801.0131.1416.22%1.09%5.33%

Compare PRGO vs Peers

Perrigo Company plc (PRGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HLN

Most directly comparable listed peer for PRGO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare PRGO against a more recognizable public peer.

Peer Set

Compare Top 5

vs HLN, CHGG, PBH, CLAR

PRGO Income Statement

Perrigo Company plc (PRGO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue4.95B4.73B3.87B4.09B4.14B4.45B4.66B4.37B4.25B
Revenue Growth %-6.33%-4.34%-18.21%5.64%1.24%7.56%4.58%-6.06%-2.75%
Cost of Goods Sold2.97B2.9B2.44B2.59B2.72B3B2.98B2.83B2.76B
COGS % of Revenue59.98%61.29%62.95%63.43%65.78%67.31%63.91%64.73%64.86%
Gross Profit
1.98B▲ 0%
1.83B▼ 7.5%
1.43B▼ 21.7%
1.49B▲ 4.3%
1.42B▼ 5.3%
1.46B▲ 2.8%
1.68B▲ 15.5%
1.54B▼ 8.2%
1.49B▼ 3.1%
Gross Margin %40.02%38.71%37.05%36.57%34.22%32.69%36.09%35.27%35.14%
Gross Profit Growth %-3.52%-7.48%-21.72%4.27%-5.26%2.77%15.46%-8.19%-3.12%
Operating Expenses1.27B1.35B1.26B1.23B1.01B1.38B1.53B1.43B2.62B
OpEx % of Revenue25.73%28.52%32.53%30.08%24.3%30.92%32.83%32.69%61.52%
Selling, General & Admin1.15B1.13B1.1B1.11B1.11B1.21B1.27B1.11B526.5M
SG&A % of Revenue23.18%23.79%28.35%27.13%26.85%27.18%27.38%25.44%12.38%
Research & Development167.7M218.6M119.2M121.7M122M123.1M122.5M112.2M95.4M
R&D % of Revenue3.39%4.62%3.08%2.98%2.95%2.77%2.63%2.57%2.24%
Other Operating Expenses10.1M-6.1M42.6M-1.1M-227.6M43.3M131.4M205M1.99B
Operating Income
598.2M▲ 0%
236.5M▼ 60.5%
174.7M▼ 26.1%
265.2M▲ 51.8%
410.4M▲ 54.8%
78.9M▼ 80.8%
151.9M▲ 92.5%
112.9M▼ 25.7%
-1.12B▼ 1094.0%
Operating Margin %12.09%5%4.51%6.49%9.92%1.77%3.26%2.58%-26.39%
Operating Income Growth %129.91%-60.46%-26.13%51.8%54.75%-80.77%92.52%-25.67%-1093.98%
EBITDA1.04B660.1M571.2M650M722.6M417.5M511.4M438.8M-1.12B
EBITDA Margin %21.09%13.95%14.76%15.9%17.46%9.38%10.98%10.03%-26.39%
EBITDA Growth %167.61%-36.71%-13.47%13.8%11.17%-42.22%22.49%-14.2%-355.74%
D&A (Non-Cash Add-back)444.8M423.6M396.5M384.8M312.2M338.6M359.5M325.9M0
EBIT453.5M419.6M265.5M133.6M383.7M16.9M165.5M107.1M0
Net Interest Income-173.4M-129M-126.5M-127.7M-125M-156M-173.8M-187.8M0
Interest Income000000000
Interest Expense173.4M129M126.5M127.7M125M156M173.8M187.8M162.5M
Other Income/Expense-318.1M54.1M-26.7M-259.3M-151.7M-218M-160.2M-193.6M-175.7M
Pretax Income
280.1M▲ 0%
290.6M▲ 3.7%
148M▼ 49.1%
5.9M▼ 96.0%
258.7M▲ 4284.7%
-139.1M▼ 153.8%
-8.3M▲ 94.0%
-80.7M▼ 872.3%
-1.3B▼ 1508.3%
Pretax Margin %5.66%6.14%3.82%0.14%6.25%-3.12%-0.18%-1.85%-30.52%
Income Tax160.5M159.6M-10.7M-38.3M389.6M-8.2M-3.9M80M104.4M
Effective Tax Rate %57.3%54.92%-7.23%-649.15%150.6%5.9%46.99%-99.13%-8.04%
Net Income
119.6M▲ 0%
131M▲ 9.5%
146.1M▲ 11.5%
-162.6M▼ 211.3%
-68.9M▲ 57.6%
-140.6M▼ 104.1%
-12.7M▲ 91.0%
-171.8M▼ 1252.8%
-1.43B▼ 729.7%
Net Margin %2.42%2.77%3.78%-3.98%-1.66%-3.16%-0.27%-3.93%-33.51%
Net Income Growth %102.98%9.53%11.53%-211.29%57.63%-104.06%90.97%-1252.76%-729.69%
Net Income (Continuing)119.6M131M158.7M44.2M-130.9M-130.9M-4.4M-160.7M-1.43B
Discontinued Operations00-12.6M-206.8M62M-9.7M-8.3M-11.1M0
Minority Interest100K100K300K000000
EPS (Diluted)
0.84▲ 0%
0.95▲ 13.1%
1.07▲ 12.6%
-1.19▼ 211.2%
-0.98▲ 17.6%
-0.97▲ 1.0%
-0.09▲ 90.3%
-1.25▼ 1231.2%
-10.29▼ 723.2%
EPS Growth %103%13.1%12.63%-211.22%17.65%1.02%90.32%-1231.2%-723.2%
EPS (Basic)0.840.951.07-1.19-0.98-0.97-0.09-1.25-10.29
Diluted Shares Outstanding142.6M138.3M136.5M136.1M133.6M134.5M135.3M137.4M138.5M
Basic Shares Outstanding142.3M137.8M136M136.1M133.6M134.5M135.3M137.4M138.5M
Dividend Payout Ratio76.17%80.08%76.93%------

PRGO Balance Sheet

Perrigo Company plc (PRGO) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets2.82B2.9B2.73B3.13B3.86B2.72B2.83B2.48B2.8B
Cash & Short-Term Investments678.7M551.1M354.3M631.5M1.86B600.7M751.3M558.8M531.6M
Cash Only678.7M551.1M354.3M631.5M1.86B600.7M751.3M558.8M531.6M
Short-Term Investments000000000
Accounts Receivable1.13B1.07B1.24B593.5M652.9M697.1M739.6M642.3M612.8M
Days Sales Outstanding83.4582.78117.2652.9957.5857.1657.9853.6152.59
Inventory806.9M878M967.3M1.06B1.02B1.15B1.14B1.08B1.15B
Days Inventory Outstanding99.27110.5144.92149.11136.78140.13139.97139.49152.03
Other Current Assets000666.9M16.1M271.8M201.1M199M504M
Total Non-Current Assets8.81B8.08B8.57B8.35B6.57B8.3B7.98B7.17B5.74B
Property, Plant & Equipment833.1M829.1M1.03B1.02B1.03B1.14B1.1B1.09B1.07B
Fixed Asset Turnover5.94x5.71x3.75x4.01x4.01x3.89x4.23x4.00x3.99x
Goodwill4.18B4.03B4.12B3.1B3B3.49B3.53B3.32B0
Intangible Assets3.38B2.86B2.99B2.49B2.15B3.29B2.99B2.43B2.35B
Long-Term Investments11.2M19.5M0000000
Other Non-Current Assets398.3M343.4M426M1.71B377.5M367.7M335.2M318.6M2.61B
Total Assets
11.63B▲ 0%
10.98B▼ 5.6%
11.3B▲ 2.9%
11.49B▲ 1.7%
10.43B▼ 9.3%
11.02B▲ 5.7%
10.81B▼ 1.9%
9.65B▼ 10.7%
8.54B▼ 11.5%
Asset Turnover0.43x0.43x0.34x0.36x0.40x0.40x0.43x0.45x0.50x
Asset Growth %-16.16%-5.55%2.9%1.65%-9.25%5.67%-1.89%-10.74%-11.53%
Total Current Liabilities1.44B1.54B1.34B1.38B1.59B1.11B1.59B1.04B1.01B
Accounts Payable450.2M474.9M520.2M451.6M411.2M537.3M477.7M495.2M474.5M
Days Payables Outstanding55.3959.7777.9463.5655.1365.4558.663.8562.78
Short-Term Debt70.4M190.2M3.4M37.3M603.8M36.2M440.6M36.4M36.6M
Deferred Revenue (Current)000000000
Other Current Liabilities000427.5M49.1M-28.4M00976.3M
Current Ratio1.96x1.89x2.04x2.27x2.43x2.44x1.79x2.38x2.76x
Quick Ratio1.40x1.32x1.32x1.50x1.79x1.41x1.07x1.34x1.63x
Cash Conversion Cycle127.33133.51184.24138.53139.23131.83139.35129.24141.84
Total Non-Current Liabilities4.02B3.78B4.16B4.45B3.69B5.06B4.45B4.28B4.59B
Long-Term Debt3.27B3.05B3.37B3.53B2.92B4.07B3.63B3.58B0
Capital Lease Obligations000132.5M147.3M189.5M000
Deferred Tax Liabilities321.9M282.3M280.6M276.2M239.3M368.2M262.3M203.2M168.9M
Other Non-Current Liabilities429.5M443.4M515.1M515M382.8M433.5M559.8M499.2M4.42B
Total Liabilities5.46B5.32B5.5B5.83B5.27B6.18B6.04B5.33B5.6B
Total Debt3.34B3.24B3.37B3.73B3.69B4.32B4.07B3.62B36.6M
Net Debt2.66B2.69B3.01B3.09B1.83B3.72B3.32B3.06B-495M
Debt / Equity0.54x0.57x0.58x0.66x0.72x0.89x0.85x0.84x0.01x
Debt / EBITDA3.20x4.91x5.90x5.73x5.11x10.36x7.97x8.25x-
Net Debt / EBITDA2.55x4.08x5.28x4.76x2.53x8.92x6.50x6.97x-
Interest Coverage3.45x1.83x1.38x2.08x3.28x0.51x0.87x0.60x-6.91x
Total Equity
6.17B▲ 0%
5.67B▼ 8.1%
5.8B▲ 2.4%
5.66B▼ 2.6%
5.15B▼ 8.9%
4.84B▼ 6.0%
4.77B▼ 1.5%
4.32B▼ 9.4%
2.94B▼ 32.0%
Equity Growth %3.58%-8.14%2.4%-2.57%-8.9%-6.01%-1.53%-9.41%-32.04%
Book Value per Share43.2740.9842.5241.5538.5636.0035.2431.4421.19
Total Shareholders' Equity6.17B5.67B5.8B5.66B5.15B4.84B4.77B4.32B2.94B
Common Stock7.89B7.42B7.36B7.12B7.04B6.94B6.84B6.73B6.75B
Retained Earnings-1.98B-1.84B-1.7B-1.86B-1.93B-2.07B-2.08B-2.25B-3.68B
Treasury Stock000000000
Accumulated OCI253.1M84.6M139.4M395M35.5M-27M10.7M-162.4M4.8M
Minority Interest100K100K300K000000

PRGO Cash Flow Statement

Perrigo Company plc (PRGO) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations698.9M593M387.8M636.2M156.3M307.3M405.5M362.9M238.5M
Operating CF Margin %14.13%12.53%10.02%15.56%3.78%6.9%8.71%8.3%5.61%
Operating CF Growth %6.72%-15.15%-34.6%64.05%-75.43%96.61%31.96%-10.51%-34.28%
Net Income119.6M131M146.1M-162.6M-68.9M-130.9M-12.7M-171.8M-1.43B
Depreciation & Amortization444.8M423.6M396.5M384.8M312.2M338.6M359.5M325.9M337.5M
Stock-Based Compensation43.8M37.7M52.2M58.5M60.1M068.8M64.4M54.6M
Deferred Taxes-48.9M-17.9M-43.9M-54.5M9.4M-50.5M-106.6M9.8M-50.8M
Other Non-Cash Items243.5M38M150.4M479.2M138.9M130.1M155M209.3M1.32B
Working Capital Changes-103.9M-19.4M-313.5M-69.2M-295.4M20M-58.5M-74.7M0
Change in Receivables3.2M21M-140.7M168.9M-159.7M100K-57.1M-11.1M30.7M
Change in Inventory-16M-98.6M-67M-170.6M-2.4M-76.7M19.4M13.7M-61.1M
Change in Payables-39.6M28.8M17M-2.7M-7.9M100.3M-65.9M54.2M-28.7M
Cash from Investing2.34B-126.8M-596.1M-187.8M1.28B-1.96B-77.5M78.8M-75.4M
Capital Expenditures-88.6M-102.6M-137.7M-170.4M-152.1M-96.4M-101.7M-118.3M-93.4M
CapEx % of Revenue1.79%2.17%3.56%4.17%3.68%2.17%2.18%2.71%2.2%
Acquisitions154.2M5.2M-565.2M4.3M1.49B-1.95B000
Investments---------
Other Investing72.5M-35.6M106.8M-21.7M-64M90.5M24.2M197.1M18M
Cash from Financing-3B-571.9M1.8M-181.1M-178.7M421.6M-187.2M-611M-220.5M
Debt Issued (Net)-2.72B-58.3M124.5M149.9M-30.6M583.6M-30.2M-437.8M0
Equity Issued (Net)-1000K-1000K900K-1000K00000
Dividends Paid-91.1M-104.9M-112.4M-123.9M-129.6M-142.4M-149.7M-152.5M-159.3M
Share Repurchases-191.5M-400M0-164.2M00000
Other Financing-1.8M-8.7M-11.2M-42.9M-18.5M-19.6M-7.3M-20.7M-61.2M
Net Change in Cash
56.4M▲ 0%
-127.6M▼ 326.2%
-196.8M▼ 54.2%
287.2M▲ 245.9%
1.23B▲ 329.5%
-1.26B▼ 202.5%
150.6M▲ 111.9%
-192.5M▼ 227.8%
-561.1M▼ 191.5%
Free Cash Flow
610.3M▲ 0%
490.4M▼ 19.6%
250.1M▼ 49.0%
465.8M▲ 86.2%
4.2M▼ 99.1%
210.9M▲ 4921.4%
303.8M▲ 44.0%
244.6M▼ 19.5%
145.1M▼ 40.7%
FCF Margin %12.34%10.36%6.46%11.39%0.1%4.74%6.53%5.59%3.41%
FCF Growth %11.23%-19.65%-49%86.25%-99.1%4921.43%44.05%-19.49%-40.68%
FCF per Share4.283.551.833.420.031.572.251.781.05
FCF Conversion (FCF/Net Income)5.84x4.53x2.65x-3.91x-2.27x-2.19x-31.93x-2.11x-0.17x
Interest Paid187.6M133.8M136.8M145.8M133M0276.9M251.4M0
Taxes Paid186.9M144.2M136.2M81.2M448M0107.5M155.7M0

PRGO Key Ratios

Perrigo Company plc (PRGO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)-50.18%1.97%2.21%2.55%-2.84%-1.28%-2.81%-0.26%-3.78%-39.29%
Return on Invested Capital (ROIC)-11.22%4.49%2.06%1.53%2.26%3.91%0.76%1.37%1.09%-17.14%
Gross Margin38.86%40.02%38.71%37.05%36.57%34.22%32.69%36.09%35.27%35.14%
Net Margin-75.99%2.42%2.77%3.78%-3.98%-1.66%-3.16%-0.27%-3.93%-33.51%
Debt / Equity0.97x0.54x0.57x0.58x0.66x0.72x0.89x0.85x0.84x0.01x
Interest Coverage-9.14x3.45x1.83x1.38x2.08x3.28x0.51x0.87x0.60x-6.91x
FCF Conversion-0.16x5.84x4.53x2.65x-3.91x-2.27x-2.19x-31.93x-2.11x-0.17x
Revenue Growth14.7%-6.33%-4.34%-18.21%5.64%1.24%7.56%4.58%-6.06%-2.75%

PRGO SEC Filings & Documents

Perrigo Company plc (PRGO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 23, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Nov 5, 2025·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 28, 2025·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 7, 2025·SEC

PRGO Frequently Asked Questions

Perrigo Company plc (PRGO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Perrigo Company plc (PRGO) reported $4.25B in revenue for fiscal year 2025. This represents a 447% increase from $778.1M in 1996.

Perrigo Company plc (PRGO) saw revenue decline by 2.8% over the past year.

Perrigo Company plc (PRGO) reported a net loss of $1.43B for fiscal year 2025.

Dividend & Returns

Yes, Perrigo Company plc (PRGO) pays a dividend with a yield of 9.88%. This makes it attractive for income-focused investors.

Perrigo Company plc (PRGO) has a return on equity (ROE) of -39.3%. Negative ROE indicates the company is unprofitable.

Perrigo Company plc (PRGO) generated $145.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PRGO

Perrigo Company plc (PRGO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.